Reference Source

Traders World Corporation · 66-41 · PAKISTAN

For Traders World Corporation · 66-41 · PAKISTAN, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is PAKISTAN; product is Himalayan Salt with Salt Pipe Inhaler | Himalayan Salt with Salt Pipe Inhaler | Himalayan Salt with Salt Pipe Inhaler; product code is 28 S - - 02 Plain Salt (Table Salt) | 28 S - - 99 Salt (Table Salt) N.E.C. | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 10/02/2014; address is Plot No. F362 , Site Metroville , Karachi, Sindh PAKISTAN, verified against its source on 2026-09-16.

Firm
Traders World Corporation verified
Import alert
66-41
Import alert name
Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
Country
PAKISTAN verified
Address
Plot No. F362 , Site Metroville , Karachi, Sindh PAKISTAN verified
Date published
10/02/2014 verified
Product code
28 S - - 02 Plain Salt (Table Salt) | 28 S - - 99 Salt (Table Salt) N.E.C. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
Product
Himalayan Salt with Salt Pipe Inhaler | Himalayan Salt with Salt Pipe Inhaler | Himalayan Salt with Salt Pipe Inhaler each item verified
FDA notes
Unapproved New Drug; Misbranded | Unapproved New Drug; Misbranded | Unapproved New Drug; Misbranded each item verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

Traders World Corporation Date Published : 10/02/2014 Plot No. F362 , Site Metroville , Karachi, Sindh PAKISTAN 28 S - - 02 Plain Salt (Table Salt) Date Published: 10/02/2014 Desc: Himalayan Salt with Salt Pipe Inhaler Notes: Unapproved New Drug; Misbranded 28 S - - 99 Salt (Table Salt) N.E.C. Date Published: 10/02/2014 Desc: Himalayan Salt with Salt Pipe Inhaler Notes: Unapproved New Drug; Misbranded 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 10/02/2014 Desc: Himalayan Salt with Salt Pipe Inhaler Notes: Unapproved New Drug; Misbranded

accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.